2020年 参加者
(as of January 31, 2020)- Research Fellow, A STAR
- Head, Ablynx a Sanofi Co
- VP Platform Sciences, Adaptimmune Therapeutics plc
- Market Dev Mgr, Adaptive Biotechnologies
- Assoc Dir Antibody Discovery, Adimab LLC
- Scientific Dir & CSO, Affilogic
- Coordination Dir, Ajinomoto Omnichem NV
- Sr Scientist, Alligator Bioscience AB
- Sr Scientist, Alligator Bioscience AB
- Sr Scientist, Alligator Bioscience AB
- Sr Scientist, Amgen Inc
- Dir Research & Early Dev Lead Oncology, Amgen Research Munich GmbH
- Project Head, Apeiron Biologics AG
- Professor & Chair, Arabian Gulf University
- CSO, ArsenalBio
- Assoc Dir & Head, AstraZeneca
- Head, Avvinity Therapeutics
- Dir Bus Dev, Batavia Biosciences BV
- Bus Development Mgr, BBI Solutions
- BioPharma Market Dev Mgr, Bio Rad Labs
- Clinical Research Scientist, BIOCAD
- Group Leader, BIOCAD
- Jr Researcher, BIOCAD
- Researcher, BIOCAD
- Scientist, BIOCAD
- CEO, Biocytogen Boston Corp
- Scientist II, Blueprint Medicines
- Scientist II, Blueprint Medicines
- Sr Principal Scientist, Boehringer Ingelheim Pharma GmbH & Co KG
- Assoc Professor of Neurosurgery & Dir, Brigham & Womens Hospital
- Assoc Dir, Caprion Biosciences Inc
- Professor, Cardiff University
- Co Founder & VP Discovery Research, Carisma Therapeutics Inc
- Scientist, Celgene Ltd
- VP R&D, Celyad
- Global Head, Celyad Inc
- Prof, Central Connecticut State University
- Bus Devloper, Cerba Research
- Professor, Charite University Berlin
- Dir, Chinese PLA General Hospital
- Sr Scientist, ChromoTek GmbH
- Professor & Investigator, CIGB
- Scientist, Compugen Ltd
- Research & Lab Dir, Cordeliers Research Ctr
- Principal Scientist, Crescendo Biologics Ltd
- Sr Scientist, Crescendo Biologics Ltd
- Bus Dev Mgr, Crown Bioscience Inc
- Scientific Account Manager, Crown Bioscience Inc
- Sr Scientist, Ctr Leon Berard
- Researcher, Daiichi Sankyo Co Ltd
- Professor, Dana Farber Cancer Institute
- Medical Oncologist, Duke University
- Graduate Student, Erasmus MC
- Postdoc Research Fellow, Erasmus MC
- Assoc Professor & Head, Erasmus University
- Full Professor, ETH Zurich
- Dir Client Relations, evitria AG
- VP Preclinical Translational Pharmacology, F star Biotechnology Ltd
- Scientific Dir, Fred Hutchinson Cancer Research Ctr
- Professor, Fukushima Medical University
- Study Director, GemPharmatech Co Ltd
- Assoc Fellow, GlaxoSmithKline
- CMO, Gossamer Bio
- Grp Leader, Hubrecht Organoid Technology Foundation
- Scientist, Hubrecht Organoid Technology Foundation
- Lab Head Advanced Cell Models Lab, iBET Instituto de Biologia Experimental Tecnologica
- CEO & Dir, Immetacyte
- CSO & COO, Immudex
- Market Dev Mgr, Immudex
- Bus Dev, Immuneed AB
- COO, Immuneed AB
- Sr Scientist & Head, Immuneed AB
- Bus Dev Mgr, ImmunXperts SA
- Sr Research Analyst Technology Eval & Med Policy, Independence Blue Cross
- Chief Researcher of BIO R&D, Individual Consultant
- Oncologist, Individual Consultant
- Principal Investigator, Innate Pharma
- Head & Professor, Institut Curie
- Professor, Institute of Cancer Research
- Head, Institute of Hematopathology Hamburg
- Global VP Sales & Marketing, IRBM Science Pk SpA
- Dir European Sales, IsoPlexis
- European Sales Mgr, IsoPlexis
- Sales Consultant, IsoPlexis
- Sr Sales Mgr, IsoPlexis
- Principal Scientist, Janssen R&D
- Sr Research Scientist, JW CreaGene
- Sr Research Scientist & Mgr, JW CreaGene
- Consultant & Sr Lecturer, Kings College London
- Lecturer, Kings College London
- Professor, Kings College London
- Professor & Chair Cancer Research, Kings College London
- Sr Clinical Lecturer & Clinician Scientist, Kings College London
- Principal Scientist, LifeArc
- Therapeutic Program Lead, Light Chain Bioscience A brand of Novimmune SA
- Dir, Ludwig Institute for Cancer Research
- Assoc Professor, Massachusetts General Hospital
- Assoc Professor & Dir, Massachusetts General Hospital
- Asst Professor Medicine, Massachusetts General Hospital
- Graduate Student, Max Delbrueck Ctr For Molecular Medicine
- Surgical Oncologist & Assoc Professor, Mayo Clinic & Foundation
- Chair Hematology & Medical Oncology & Assoc Professor, Mayo Clinic Labs
- President, MEDICLINK Regenerative Cellular Therapy Ctr
- PostDoc Scientist, Melanoma Institute Australia
- Medical Oncologist & Dir, Memorial Sloan Kettering Cancer Ctr
- Exec Medical Dir & Head of Companion Diagnostics, Merck & Co Inc
- Lab Head, Merck Healthcare KGaA
- Scientific Liaison, Merck KGaA
- Sr VP Global Clinical Dev, Merck Research Labs
- Sr Scientist, Merus NV
- Clinical Assessor, MHRA
- Medical Assessor, MHRA
- Pre-clinical Assessor, MHRA
- Quality Assessor, MHRA
- Head of Cell Engineering R&D, MilliporeSigma
- Sr Product Mgr, MilliporeSigma
- Founder & CEO, MindPeak GmbH
- Assoc Dir R&D, MorphoSys AG
- Principal Tech Asst, MorphoSys AG
- CEO, multimmune GmbH
- PostDoc Fellow, Netherlands Cancer Institute
- Dir Lab Animal Sciences Program, NIH NCI
- COO & CMO & Vice Chair, NKMax America Inc
- Sr Research Scientist, Orionis Biosciences NV
- Sr Scientist, Ottawa Health Research Institute
- Scientist, Oxford Genetics Ltd
- Sr Scientist, Oxford Genetics Ltd
- App Dev Scientist, Oxford Nanoimaging Ltd ONI
- Business Developer, Oxford Nanoimaging Ltd ONI
- CEO, Panolos Bioscience
- CSO, Panolos Bioscience
- Research Scientist, Panolos Bioscience
- Clinical Assessor, Paul Ehrlich Institut
- Lab Head, Peter MacCallum Cancer Ctr
- Dir In Vivo Pharmacology & Oncology, Pfizer Inc
- Dir Clinical Dev, PharmaEngine Inc
- Sr Dir Translational Business Solutions, Precision for Medicine
- Global Head, Precision for Medicine Oncology & Rare Disease
- Sr Dir Strategic Dev, Precision for Medicine Oncology & Rare Disease
- Grp Leader Cellular Test Systems & Head, ProQinase GmbH
- Mgr Bus Dev, ProQinase GmbH
- Professor, Cancer Cell Biology, Queen Mary University of London
- Asst Professor, Queens University
- CSO, Refuge Biotechnologies Inc
- Exec Dir ImmunoOncology Dev, Regeneron Pharmaceuticals Inc
- Research Fellow, Regeneron Pharmaceuticals Inc
- Sr Dir Bispecifics, Regeneron Pharmaceuticals Inc
- Sr Dir Immunology & Inflammation, Regeneron Pharmaceuticals Inc
- Chief Dev Officer, RhoVac ApS
- Principal Scientist & Grp Leader, Roche Diagnostics GmbH
- Global Head External Innovation, Roche Innovation Ctr Penzberg
- Grp Leader Preclinical Imaging & Histology Core, Roche Innovation Ctr Zurich
- Sr Scientist, Roche Innovation Ctr Zurich
- Professor & Dir Cellular Therapeutics, Royal Free London Hospital NHS Foundation Trust
- President, Samyang Biopharm USA Inc
- VP Research, Samyang Biopharmaceuticals Corp
- CSO, Scancell Ltd
- Exec Dir Antibody Discovery & Scientific Advisor, Shanghai Henlius Biotech Co Ltd
- VP R&D, Shattuck Labs Inc
- CBO, Sino Biological US Inc
- Sr Scientist, SOTIO a s
- Professor, Southampton General Hospital
- Professor & Dir i4PhD Cancer Immunology Pathway, Southampton General Hospital
- R&D & Innovation Officer, Swansea University
- Sr VP Immunology & GM, Swedish Orphan Biovitrum AB
- Project Dir, Symphogen AS
- Medical Dir, Syneos Health
- President, Sysmex R&D Ctr Europe GmbH
- Sr VP, T Cure BioScience Inc
- Asst Professor, Tufts Medical Ctr
- Assoc Professor, University College London
- Professor, University Hospital Tuebingen
- Clinical Scientist & Honorary Medical Oncologist, University of Leeds
- Student, University of Leeds
- PostDoc Research Assoc, University of Manchester
- Postdoc, University of Oxford
- Chair Gene Immunotherapy, University of Regensburg
- Sr PostDoc Research Fellow Antibody & Vaccine Grp, University of Southampton
- Professor & Deputy Head, University Of Stuttgart
- Assoc Professor, Utrecht University
- VP Scientific Affairs, Vaccibody AS
- Professor, Vrije University Brussels
- Professor, VU Medical Ctr
- Physician & Researcher, VU University Medical Ctr Amsterdam
- Dir, Xencor Inc
- Mgr, Y mAbs Therapeutics Inc
- Asst Professor, Zarqa University
- Sr VP Discovery Research, Zymeworks Inc
